Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190.
about
The CK1 Family: Contribution to Cellular Stress Response and Its Role in CarcinogenesisDevelopment of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic DysfunctionControl of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetInhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathwayMicrotubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model.Conserved and distinct modes of CREB/ATF transcription factor regulation by PP2A/B56gamma and genotoxic stressMyocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38α MAPK inhibitors.Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cellsSB203580 increases G-CSF production via a stem-loop destabilizing element in the 3' untranslated region in macrophages independently of its effect on p38 MAPK activity.Target molecules of food phytochemicals: food science bound for the next dimension.Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosisCasein kinase 1α: biological mechanisms and theranostic potential.
P2860
Q21129297-767A4623-B767-48BC-BD8B-5D7AB1FED237Q27679012-7C31E340-F731-47C4-8BE3-955580444AF9Q28070887-B6D757F4-D5B3-44A2-862E-B52668DECDA4Q28481465-CDC4C0AF-7541-44FD-B30F-7E2C647E7C9BQ28553120-160CF585-807F-4AFB-B087-DF92EA35C3F0Q33668766-86CE3B22-3524-4D53-BC9C-DA7F2D964F1FQ33917079-3232F5FB-3C93-4F64-8613-FD9A1AE2854CQ34006977-06CAC97B-FDBF-4877-B2D1-EE79253AE282Q34868170-9260CE14-428E-4981-AAD1-00F066958678Q36469025-B27A7E97-2440-49A5-B38E-7054E5BA7097Q37989366-B0D044A7-C857-45F6-8A93-32BCDEACCC7DQ41084457-75F4EBB0-731D-42D4-8EC5-195CF23A8A80Q54940982-C26910E6-8C26-4FF7-9F0D-9084D6987E02
P2860
Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@en
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@nl
type
label
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@en
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@nl
prefLabel
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@en
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@nl
P2093
P2860
P1433
P1476
Non-specific in vivo inhibitio ...... itors SB 203580 and SB 202190.
@en
P2093
Leah M Williams
Michael J Bowler
Naval P Shanware
Randal S Tibbetts
P2860
P304
P356
10.5483/BMBREP.2009.42.3.142
P577
2009-03-01T00:00:00Z